1)Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, et al: HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1: 50-61, 1995
2)2019年度日本医療研究開発機構委託研究開発費(AMED補助金)新興・再興感染症に対する革新的医薬品等開発推進研究事業「HTLV-1の疫学研究及び総合対策に資する研究」班: HTLV-1感染の診断指針. 2019 http://www.jpeds.or.jp/modules/activity/index.php?content_id=320(最終閲覧日:2021年7月6日)
3)Gotuzzo E, Cabrera J, Deza L, Verdonck K, Vandamme AM, et al: Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis. Clin Infect Dis 39: 939-944, 2004
4)Casseb J: Is human T cell lymphotropic type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) syndrome a neglected disease? PLoS Negl Trop Dis 3: e487, 2009[doi: 10.1371/journal.pntd.0000487]
5)Geevasinga N, Loy CT, Menon P, de Carvalho M, Swash M, et al: Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: a systematic review using individual patient data. Clin Neurophysiol 127: 2684-2691, 2016
6)Liberski PP, Buczyński J, Yanagihara R, Mora C, Gibbs CJ, et al: Ultrastructural pathology of a Chilean case of tropical spastic paraparesis/human T-cell lymphotropic type I-associated myelopathy (TSP/HAM). Ultrastruct Pathol 23: 157-162, 1999
7)Kuroda Y, Sugihara H: Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations. J Neurol Sci 106: 199-205, 1991
8)Ando R, Nishikawa N, Tsujii T, Iwaki H, Yabe H, et al: Human T-lymphotropic virus type-I (HTLV-I)-associated myelopathy with bulbar palsy-type amyotrophic lateral sclerosis-like symptoms. Intern Med 54: 1105-1107, 2015
9)Matsuzaki T, Nakagawa M, Nagai M, Nobuhara Y, Usuku K, et al: HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. J Neurovirol 6: 544-548, 2000